Display options
Share it on

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26:18A-22A. doi: 10.1155/2015/167484.

Canadian Public Health Laboratory Network laboratory guidelines for the diagnosis of neurosyphilis in Canada.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Tom Wong, Kevin Fonseca, Max A Chernesky, Richard Garceau, Paul N Levett, Bouchra Serhir

Affiliations

  1. Public Health Agency of Canada, Ottawa, Ontario;
  2. Alberta Provincial Laboratory for Public Health, Calgary, Alberta;
  3. McMaster University, Hamilton, Ontario;
  4. Hopital Dr George Dumont, Moncton, New Brunswick;
  5. Saskatchewan Disease Control Laboratory, Regina, Saskatchewan;
  6. Institut national de santé publique du Quebec-LSPQ, Sainte-Anne-de-Bellevue, Quebec.

PMID: 25798161 PMCID: PMC4353983 DOI: 10.1155/2015/167484

Abstract

Neurosyphilis refers to infection of the central nervous system by Treponema pallidum, which may occur at any stage. Neurosyphilis has been categorized in many ways including early and late, asymptomatic versus symptomatic and infectious versus non-infectious. Late neurosyphilis primarily affects the central nervous system parenchyma, and occurs beyond early latent syphilis, years to decades after the initial infection. Associated clinical syndromes include general paresis, tabes dorsalis, vision loss, hearing loss and psychiatric manifestations. Unique algorithms are recommended for HIV-infected and HIV-uninfected patients, as immunocompromised patients may present with serologic and cerebrospinal fluid findings that are different from immunocompetent hosts. Antibody assays include a VDRL assay and the FTA-Abs, while polymerase chain reaction for T. pallidum can be used as direct detection assays for some specimens. This chapter reviews guidelines for specimen types and sample collection, and identifies two possible algorithms for use with immunocompromised and immunocompetent hosts using currently available tests in Canada, along with a review of treatment response and laboratory testing follow-up.

Keywords: CD4; CSF; Congenital; HIV; Neurosyphilis

References

  1. Curr Infect Dis Rep. 2009 Mar;11(2):127-34 - PubMed
  2. Sex Transm Dis. 1996 May-Jun;23(3):184-9 - PubMed
  3. FEMS Microbiol Lett. 1990 Mar 15;56(3):233-8 - PubMed
  4. Eur J Neurol. 2006 Sep;13(9):913-22 - PubMed
  5. MMWR Recomm Rep. 2010 Dec 17;59(RR-12):1-110 - PubMed
  6. AIDS. 1991 Apr;5(4):419-23 - PubMed
  7. Br J Vener Dis. 1981 Aug;57(4):232-7 - PubMed
  8. Acta Dermatovenerol Alp Pannonica Adriat. 2007 Dec;16(4):135-41 - PubMed
  9. West J Med. 1995 Dec;163(6):552-9 - PubMed
  10. Clin Infect Dis. 2008 Oct 1;47(7):893-9 - PubMed
  11. J Clin Lab Anal. 2006;20(6):233-8 - PubMed
  12. Laryngoscope. 1979 Aug;89(8):1273-88 - PubMed
  13. CNS Neurosci Ther. 2010 Oct;16(5):e157-68 - PubMed
  14. JAMA. 2003 Sep 17;290(11):1510-4 - PubMed
  15. West J Med. 1988 Jul;149(1):47-57 - PubMed
  16. Curr Infect Dis Rep. 2005 Jul;7(4):277-284 - PubMed
  17. Am J Med. 1951 Apr;10(4):463-7 - PubMed
  18. J Chronic Dis. 1955 Sep;2(3):311-44 - PubMed
  19. Arch Neurol. 1995 Jan;52(1):68-72 - PubMed
  20. Clin Infect Dis. 2009 Mar 15;48(6):816-21 - PubMed
  21. Genitourin Med. 1987 Apr;63(2):77-82 - PubMed

Publication Types